Screener
Ionis Pharmaceuticals IONS Cumulative Cost Basis
Cumulative Cost Basis at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| June 30, 2026 | Amortized / Cost | Gross Unrealized / Gains | Gross Unrealized / Losses | Estimated / Fair Value |
|---|---|---|---|---|
| Debt securities issued by the U.S. Treasury | 181,168 | - | (1,340) | 179,828 |
| Debt securities issued by states of the U.S. and political subdivisions of the states | 731 | - | (1) | 730 |
| Total debt securities with a maturity of more than one year | 651,145 | 91 | (3,911) | 647,325 |
| Total available-for-sale debt securities | $$1,788,862 | $516 | $(5,012) | 1,784,366 |
| Equity securities: | ||||
| Publicly traded equity securities included in other current assets (2) | $$11,897 | $45,670 | $(9,799) | 47,768 |
| Privately held equity securities included in deposits and other assets (3) | 10,000 | 9,816 | - | 19,816 |
| Total equity securities | 21,897 | 55,486 | (9,799) | 67,584 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's cumulative cost basis?
- Ionis Pharmaceuticals (IONS) reported cumulative cost basis of $1.79B in Q2 2026.
- How has Ionis Pharmaceuticals's cumulative cost basis changed year-over-year?
- Ionis Pharmaceuticals's cumulative cost basis decreased by 12.6% year-over-year, from $2.05B to $1.79B.
- What is the long-term trend for Ionis Pharmaceuticals's cumulative cost basis?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's cumulative cost basis has grown at a 17.1% compound annual growth rate (CAGR), from $1.25B to $2.35B.
Ask your AI about Ionis Pharmaceuticals's cumulative cost basis.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude